Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire John Paulson and Jacob Gottlieb Boost Their Stakes in Enzymotec Ltd (ENZY)

John Paulson reinforces his bullish views on Enzymotec Ltd (NASDAQ:ENZY). A recent 13G filing shows that his fund, Paulson & Co, more than doubled its passive stake in the company from 1.7 million shares to about 4.2 million. The new stake represents nearly 20% ownership of Enzymotec and is worth approximately $112 million.

largest hedge funds in the world

Jacob Gottlieb‘s Visium Asset Management is another hedge fund that has recently raised its interest in Enzymotec Ltd (NASDAQ:ENZY). The fund increased its stake in the company from the previously held 690 thousand shares to 1.14 million, which represent 5.2% of Enzymotec’s common stock and are worth approximately $31 million. Other funds holding stock of Enzymotec Ltd (NASDAQ:ENZY) include Richard Driehaus‘ Driehaus Capital with 83.9 thousand shares worth $2.27 million and Gavin Saitowitz‘ Springbok Capital with 10 thousand shares worth $0.27 million.

Enzymotec Ltd (NASDAQ:ENZY) is a leading global supplier of specialty lipid-based products and solutions. Since its initial public offering held at a price of $14 per share in September 2013, the company nearly doubled its share price, selling 5.4 million shares at $28 per share in its first seasoned equity offering closed on the 5th of March, 2014. In 2013 Enzymotec generated revenues of $64.98 million,  nearly double the result of $37.87 million for 2012, and currently trades at a P/E ratio of roughly 26 versus the industry average of 37.6. Analysts estimate an increase in earnings per share to $0.86 for 2014 from the $0.48 observed in 2013 and, on average, recommend that investors buy the stock.

Services, Technology, and Basic Materials represent approximately 2/3 of Paulson & Co’s equity portfolio value, with the largest stake (7.2% worth $1.46 billion) invested in 55.7 million shares of Extended Stay America Inc (NYSE:STAY). Other significant investments include 35.2 million shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) and about 6 million shares of Time Warner Cable Inc (NYSE:TWC), with an aggregate value of  the holdings of $2.19 billion. Recently, it has been revealed that the hedge fund seeks to acquire two beachfront hotels in Puerto Rico.

Disclosure: none.

Recommended reading:

Viking Global Boosts Its Stake in Illumina, Inc. (ILMN)

Becker Drapkin Management Cuts Its Stake in Pixelworks, Inc. (PXLW)

Peter Keane Likes Financial And Transportation Stocks

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...